THE LELAND STANFORD JUNIOR UNIVERSITY
STANFORD, California
Total Received
$207.7M
Total Awards
86
State
California
Last Updated
Mar 20, 2026
Yearly Funding Trend
$180.7M24
$26.2M25
$807K26
Top 50 Awards to THE LELAND STANFORD JUNIOR UNIVERSITY
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P50CA186781_075 MAYO CLINIC MULTIPLE MYELOMA SPORE - THE MAYO CLINIC MULTIPLE MYELOMA SPORE (SPORE) IS A DYNAMIC, PRODUCTIVE, TRANSLATIONAL CANCER RESEARCH PROGRAM BASED AT ALL THREE MAYO CLINIC… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | AZ-90 | 2024 | $21,720,909 |
ASST_NON_P01CA229100_075 MOLECULAR DIAGNOSIS, PROGNOSIS, AND THERAPEUTIC TARGETS IN LYMPHOMA - THIS APPLICATION IS SUBMITTED ON BEHALF OF THE LYMPHOMA AND LEUKEMIA MOLECULAR PROFILING PROJECT (LLMPP), A L… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | AZ-90 | 2024 | $10,237,993 |
ASST_NON_W81XWH1910534_097 A MULTIDISCIPLINARY TRANSLATIONAL APPROACH TO INVESTIGATE THE MECHANISMS, PREDICTORS, AND PREVENTION OF PERSISTENT POST-TRAUMATIC HEADACHE EXTEND THE PERIOD OF PERFORMANCE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SCOTTSDALE, AZ-01 | 2024 | $9,999,820 |
ASST_NON_U1355158_075 LIVING ORGAN DONATION REIMBURSEMENT PROGRAM (LODRP) | Department of Health and Human Services Health Resources and Services Administration | 93.134 GRANTS TO INCREASE ORGAN DONATION | SCOTTSDALE, AZ-01 | 2025 | $9,449,999 |
ASST_NON_U54CA274504_075 MATHEMATICAL ONCOLOGY SYSTEMS ANALYSIS IMAGING CENTER (MOSAIC) - SUMMARY: OVERALL: MATHEMATICAL ONCOLOGY SYSTEMS ANALYSIS IMAGING CENTER GLIOBLASTOMA (GBM), THE MOST AGGRESSIVE PR… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | AZ-90 | 2024 | $6,255,021 |
ASST_NON_U54CA224018_075 OVERCOMING DRUG RESISTANCE IN MULTIPLE MYELOMA - THIS SUPPLEMENT WILL ALLOW THE MAYO CLINIC/UNIVERSITY OF MINNESOTA MYELOMA DRSC TO PROVIDE UNIQUE RESOURCES AND SUPPORT TO DR. CON… | Department of Health and Human Services National Institutes of Health | 93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT | SCOTTSDALE, AZ-01 | 2024 | $5,994,141 |
ASST_NON_U01DK073983_075 ADVANCING SCIENCE FOR THE DIAGNOSIS AND TREATMENT OF GASTROPARESIS - SUMMARY GASTROPARESIS AND FUNCTIONAL DYSPEPSIA ARE COMMON DISORDERS THAT CAN CAUSE CHRONIC NAUSEA AND VOMITING… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $5,890,472 |
ASST_NON_R01AI128729_075 MECHANISMS OF IL-33 SECRETION IN ALLERGIC DISEASES - PROJECT SUMMARY/ABSTRACT THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO INVESTIGATE THE FUNDAMENTAL IMMUNOLOGICAL MECHANISMS I… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $5,603,258 |
ASST_NON_R01DK092460_075 FAT IN PANCREATITIS - A FOCUS ON HYPERTRIGLYCERIDEMIC PANCREATITIS - ACUTE PANCREATITIS (AP) AFFECTS ≈ 275,000/ YEAR IN THE USA, AND IS THE COMMONEST GASTROENTEROLOGICAL CAUSE OF… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | AZ-90 | 2024 | $5,529,418 |
ASST_NON_R01AI108682_075 HOW BETA-CATENIN EXPANDS FOXP3+RORGAMMAT+ PRO-INFLAMMATORYT-REGULATORY CELLS - RENEWAL - ABSTRACT THE PLASTICITY AND FUNCTIONAL DIVERSITY OF REGULATORY T CELLS (TREGS) IS ESSENTIA… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | AZ-90 | 2024 | $5,098,154 |
ASST_NON_R37AI071106_075 MECHANISMS OF ALLERGEN-INDUCED TYPE 2 IMMUNITY - THE LONG-TERM OBJECTIVE OF THIS GRANT IS TO INVESTIGATE HOW AIRWAY EXPOSURE TO NATURAL ALLERGENS LEADS TO DEVELOPMENT OF TYPE 2 I… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | AZ-90 | 2024 | $4,682,378 |
ASST_NON_U01CA220378_075 QUANTIFYING MULTISCALE COMPETITIVE LANDSCAPES OF CLONAL DIVERSITY IN GLIOBLASTOMA - ABSTRACT GLIOBLASTOMA (GBM) EXHIBITS PROFOUND INTRATUMORAL MOLECULAR HETEROGENEITY THAT CONTRI… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | SCOTTSDALE, AZ-01 | 2024 | $4,208,560 |
ASST_NON_RF1AG062110_075 MICROGLIAL APOE IN NEUROINFLAMMATION AND ALZHEIMER'S DISEASE - ABSTRACT ALZHEIMER DISEASE (AD) IS THE MOST COMMON CAUSE OF DEMENTIA AND IS CHARACTERIZED BY EXTRACELLULAR PLAQUES… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | AZ-90 | 2024 | $3,967,967 |
ASST_NON_U01CA250481_075 IMAGE-BASED MODELS OF TUMOR-IMMUNE DYNAMICS IN GLIOBLASTOMA - ABSTRACT THE USE OF IMMUNOTHERAPY TO TREAT CANCER CONTINUES TO GENERATE HOPE AND EXCITEMENT AMONG THOSE INVOLVED IN C… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $3,775,245 |
ASST_NON_R01HL142992_075 EFFECTS OF RARE VARIANTS AND ANCESTRY ON BETA AGONIST RESPONSE IN ASTHMA AND COPD - SUMMARY SURVEILLANCE TRIALS SUGGEST THAT THE RISK FOR LIFE-THREATENING ASTHMA EXACERBATIONS AND… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | AZ-90 | 2025 | $3,722,238 |
ASST_NON_RF1AG062077_075 NOVEL GENETIC MODIFIERS OF C9ORF72 AND TAU TOXICITY - HEXANUCLEOTIDE (GGGGCC) REPEAT EXPANSIONS IN C9ORF72 ARE THE LEADING GENETIC CAUSE OF FRONTOTEMPORAL DEMENTIA (FTD) AND AMYOT… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | AZ-90 | 2024 | $3,680,731 |
ASST_NON_R01HL133501_075 ACTIVATION OF THE SECRETIN RECEPTOR AS A STRATEGY FOR THE TREATMENT OF HEART FAILURE - PROJECT SUMMARY/ABSTRACT HEART FAILURE IS A MAJOR CAUSE OF MORBIDITY AND MORTALITY IN THE PO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | AZ-90 | 2024 | $3,671,567 |
ASST_NON_R01HL117823_075 TYPE 2 INNATE LYMPHOID CELLS AND ASTHMA - PROJECT SUMMARY/ABSTRACT THIS PROJECT'S LONG-TERM GOAL IS TO UNDERSTAND ASTHMA'S IMMUNOLOGICAL MECHANISMS. AIRWAY INFLAMMATION IN PATIEN… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $3,498,756 |
ASST_NON_HT94252410232_097 PHASE 1 CLINICAL TRIAL USING AUTOLOGOUS, MUC1-ACTIVATED T CELLS EXPANDED FROM PERIPHERAL BLOOD IN PATIENTS WITH RELAPSED AND RESISTANT OVARIAN CANCER | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SCOTTSDALE, AZ-01 | 2024 | $3,291,419 |
ASST_NON_R01CA257558_075 DRUG ELUTING INJECTABLE BIOMATERIALS FOR NEXT GENERATION CHEMOEMBOLIZATION - ABSTRACT HEPATOCELLULAR CARCINOMA (HCC), THE MOST COMMON TYPE OF LIVER CANCER, IS A MAJOR WORLDWIDE PU… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $3,173,416 |
ASST_NON_R01AI169530_075 ALLERGEN-INDUCED EXTRACELLULAR DNA IN TYPE 2 IMMUNITY - PROJECT SUMMARY/ABSTRACT THE LONG-TERM OBJECTIVE OF THIS PROJECT IS TO INVESTIGATE THE FUNDAMENTAL IMMUNOLOGICAL MECHANISM… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | AZ-90 | 2024 | $3,163,994 |
ASST_NON_R01DC019114_075 OPTIMIZING A PATIENT-SPECIFIC REGENERATIVE LARYNX IMPLANT FOR RESTORATION OF VOICE - ABSTRACT THE LARYNX GOVERNS OUR MOST BASIC LIFE-SUSTAINING FUNCTIONS AND SERVES AS THE FOUNDAT… | Department of Health and Human Services National Institutes of Health | 93.173 RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS | SCOTTSDALE, AZ-01 | 2024 | $3,070,095 |
ASST_NON_R01CA264048_075 EPIGENETIC MECHANISMS OF CARCINOGENESIS BY PARVIMONAS MICRA, AN ORAL CAVITY COMMENSAL TURNED COLON CANCER PATHOGEN - PROJECT SUMMARY ABSTRACT COLORECTAL CANCER (CRC) IS AMONG THE… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $3,068,738 |
ASST_NON_R01HL137193_075 HEMORRHAGE CONTROL IN THE IRREVERSIBLE ANTICOAGULATED PATIENT - PROJECT SUMMARY/ABSTRACT HEMORRHAGE IN A SETTING OF ANTICOAGULATION (ACA) IS A SERIOUS MEDICAL EMERGENCY ASSOCIATED… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $2,952,307 |
ASST_NON_R01HL162747_075 STRATEGIES TO ENHANCE ENGINEERED HEART TISSUE BASED MYOCARDIAL REPAIR - PROJECT SUMMARY ISCHEMIC HEART DISEASE, SUCH AS UNSTABLE CORONARY ANGINA OR MYOCARDIAL INFARCTION, OFTEN LE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $2,906,845 |
ASST_NON_R01HL156855_075 CARDIOMYOCYTE NON-AUTONOMOUS FACTORS AND CARDIAC REGENERATION IN LARGE MAMMALS - PROJECT SUMMARY IN CONTRAST TO THE CARDIOMYOCYTES (CMS) FROM LOWER VERTEBRATES, ADULT MAMMALIAN CM… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $2,675,195 |
ASST_NON_R01HL140951_075 TREATMENT OF ARTERIAL ANEURYSMS USING AN INJECTABLE BIOMATERIAL - ABSTRACT ARTERIAL ANEURYSM RUPTURE HAS A VERY HIGH FATALITY RATE. THEY CAN BE FUSIFORM OR SACCULAR IN SHAPE AND C… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $2,624,205 |
ASST_NON_R01HL165176_075 BIOMATERIALS FOR EMBOLIZATION AND ABLATION OF ARTERIO-VENOUS MALFORMATIONS - ABSTRACT ARTERIOVENOUS MALFORMATION (AVM) IS AN ABNORMAL CONNECTION BETWEEN AN ARTERY AND A VEIN THAT… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $2,585,948 |
ASST_NON_R61NS113315_075 BIOMARKER SIGNATURE TO PREDICT THE PERSISTENCE OF POST-TRAUMATIC HEADACHE - ABSTRACT THERE IS CURRENTLY NO RECOGNIZED WAY OF ACCURATELY PREDICTING WHO WILL RECOVER FROM POST-TRAUM… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | AZ-90 | 2024 | $2,476,568 |
ASST_NON_R01CA271431_075 STAT5/OLIG2 REGULATION OF GBM THERAPEUTIC RESISTANCE AND RECURRENCE - RESUBMIT 3.22 - PROJECT SUMMARY GLIOBLASTOMA (GBM) IS AMONG THE MOST LETHAL HUMAN CANCERS WITH EXTENSIVE GENE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $2,326,295 |
ASST_NON_R01DK130566_075 HEALING ENTEROCUTANEOUS FISTULAS USING BIOENGINEERED BIOMATERIALS - ABSTRACT ENTEROCUTANEOUS FISTULA (ECF) IS AN ABNORMAL CONNECTION BETWEEN THE BOWEL AND SKIN. IT CAN BE ASSOCIAT… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | AZ-90 | 2024 | $2,223,844 |
ASST_NON_R33NS113315_075 BIOMARKER SIGNATURE TO PREDICT THE PERSISTENCE OF POST-TRAUMATIC HEADACHE - ABSTRACT THERE IS CURRENTLY NO RECOGNIZED WAY OF ACCURATELY PREDICTING WHO WILL RECOVER FROM POST-TRAUM… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | AZ-90 | 2024 | $2,111,462 |
ASST_NON_R01DK132651_075 ROLE OF SIRT7 IN THE PANCREATIC BETA CELLS - PROJECT SUMMARY Β CELL DYSFUNCTION IS CRITICAL FOR THE PATHOGENESIS OF TYPE 2 DIABETES MELLITUS (T2DM). STUDIES SUGGESTED THAT OVER-NU… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $2,054,025 |
ASST_NON_R01AI147652_075 MOLECULAR FUNCTIONS OF TCF-1 IN DP THYMOCYTES - PROJECT SUMMARY THYMIC DEVELOPMENT IS HIGHLY RESPONSIBLE FOR SHAPING A HEALTHY AND BALANCED T CELL IMMUNITY. LIKE OTHER DEVELOPMENT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $2,032,256 |
ASST_NON_R01HL142627_075 MYOCARDIAL REPAIR WITH A NOVEL ENGINEERED CARDIAC MUSCLE PATCH - PROJECT SUMMARY CELLULAR TRANSPLANTATION HAS EMERGED AS A PROMISING THERAPEUTIC APPROACH FOR MYOCARDIAL REPAIR. HO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | AZ-90 | 2025 | $1,967,131 |
ASST_NON_U01CA269264_075 FLEXIBLE NLP TOOLKIT FOR AUTOMATIC CURATION OF OUTCOMES FOR BREAST CANCER PATIENTS - PROJECT SUMMARY/ABSTRACT BREAST CANCER HAS THE LARGEST NUMBER OF NEW CASES IN WORLD (11.7%). A… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $1,905,455 |
ASST_NON_R01DK119646_075 PATHOGENESIS OF INFECTION IN PANCREATITIS: FROM STERILE INFLAMMATION TO SEPSIS - PROJECT SUMMARY: ACUTE PANCREATITIS (AP) AFFECTS @ 275,000/ YEAR IN THE USA. AP STARTS SUDDENLY AN… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $1,903,714 |
ASST_NON_R01AI170649_075 CONTROL OF ANTIVIRAL MEMORY CD8+ T CELL LONGEVITY BY EXTRACELLULAR ATP SENSING - PROJECT SUMMARY: DEVELOPMENT OF LONG-LIVED MEMORY CD8+ T CELLS IS PARAMOUNT FOR THE CONTROL OF VIR… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $1,894,856 |
ASST_NON_R01CA234181_075 CREDENTIALING A GENETICALLY ENGINEERED CLINICALLY-RELEVANT MOUSE MODEL OF MULTIPLE MYELOMA - PROJECT SUMMARY/ABSTRACT THALIDOMIDE (THAL) AND ITS DERIVATIVES, LENALIDOMIDE (LEN) AN… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | AZ-90 | 2024 | $1,883,437 |
ASST_NON_R01GM141003_075 IMPACT OF MEMBRANE COMPOSITION ON CHOLECYSTOKININ RECEPTOR STRUCTURE AND FUNCTION - PROJECT SUMMARY/ABSTRACT CHOLECYSTOKININ ACTS ON TYPE 1 RECEPTORS (CCK1RS) PRESENT ON VAGAL AF… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | AZ-90 | 2024 | $1,863,035 |
ASST_NON_R01CA272426_075 PRECLINICAL OPTIMIZATION OF BCMA DIRECTED T CELL THERAPY - PROJECT SUMMARY THE PILLARS OF MULTIPLE MYELOMA (MM) THERAPY ARE DNA ALKYLATORS (CYCLOPHOSPHAMIDE, MELPHALAN), PROTEASOM… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $1,834,540 |
ASST_NON_R01AG080037_075 THE ROLE OF LYMPH NODE STRUCTURAL ORGANIZATION IN NAÏVE T CELL DECLINE WITH AGE - PROJECT SUMMARY/ABSTRACT THE PROJECT GOAL IS TO UNDERSTAND HOW AGE-ASSOCIATED CHANGES TO THE LYMP… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $1,828,813 |
ASST_NON_HT94252510007_097 PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF CARDIOVASCULAR FAILURE IN ACUTE PANCREATITIS | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SCOTTSDALE, AZ-01 | 2025 | $1,665,000 |
ASST_NON_R01GM132095_075 MOLECULAR BASIS OF ACTIVATION OF THE PROTOTYPIC CLASS B G PROTEIN-COUPLED SECRETIN RECEPTOR - PROJECT SUMMARY/ABSTRACT OUR OVERALL OBJECTIVE IS TO ELUCIDATE THE MOLECULAR BASIS OF… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | AZ-90 | 2025 | $1,505,692 |
ASST_NON_R01FD006102_075 A PROSPECTIVE, RANDOMIZED, MULTI-CENTERED, PLACEBO-CONTROLLED CLINICAL TRIAL OF ORAL VANCOMYCIN IN ADULTS WITH PRIMARY SCLEROSING CHOLANGITIS - PROJECT SUMMARY PRIMARY SCLEROSING… | Department of Health and Human Services Food and Drug Administration | 93.103 FOOD AND DRUG ADMINISTRATION RESEARCH | AZ-90 | 2024 | $1,499,993 |
ASST_NON_R01DK123138_075 VALIDATION OF PERIPHERAL CGRP SIGNALING AS A TARGET FOR THE TREATMENT OF PAIN IN CHRONIC PANCREATITIS - ABSTRACT CHRONIC PANCREATITIS REMAINS A COMMON AND CHALLENGING CLINICAL SYN… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | AZ-90 | 2024 | $1,433,750 |
ASST_NON_R37CA276047_075 TARGETING PP4 TO IMPROVE OVARIAN CANCER RESPONSE TO IMMUNOTHERAPY - PROJECT SUMMARY/ABSTRACT HIGH-GRADE SEROUS OVARIAN CANCER HAS THE HIGHEST MORTALITY RATE OF ALL GYNECOLOGIC CA… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | SCOTTSDALE, AZ-01 | 2024 | $1,403,025 |
ASST_NON_R01HL167811_075 OPPORTUNISTIC SCREENING FOR ASCVD USING A MULTIMODAL DEEP LEARNING RISK PREDICTION MODEL - PROJECT SUMMARY ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD), SUCH AS STROKE AND HEART… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | AZ-90 | 2024 | $1,382,292 |
ASST_NON_R01HL172784_075 ELECTRICALLY CONDUCTIVE STEM CELL DERIVED MICROENGINEERED HEART TISSUE FOR REGENERATION OF INJURED MYOCARDIUM - PROJECT SUMMARY ISCHEMIC HEART DISEASE IS A LEADING CAUSE OF MORBID… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | AZ-90 | 2024 | $1,361,276 |
ASST_NON_R01HL179093_075 AN IMAGE-GUIDED MICROROBOTIC DRUG DELIVERY METHOD FOR PREVENTIVE VASCULAR INTERVENTIONS - PROJECT SUMMARY/ ABSTRACT END-STAGE KIDNEY DISEASE (ESKD) AFFECTS OVER 800,000 AMERICANS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SCOTTSDALE, AZ-01 | 2025 | $1,355,116 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.837 — CARDIOVASCULAR DISEASES RESEARCH$31.5M
93.397 — CANCER CENTERS SUPPORT GRANTS$28.0M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$25.8M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$19.5M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$16.0M
93.395 — CANCER TREATMENT RESEARCH$15.8M
93.396 — CANCER BIOLOGY RESEARCH$10.8M
93.866 — AGING RESEARCH$10.5M
93.134 — GRANTS TO INCREASE ORGAN DONATION$9.4M
93.394 — CANCER DETECTION AND DIAGNOSIS RESEARCH$6.3M
Source: USAspending.gov · All Recipients · California